Korshunov A G, Sycheva R V, Golanov A V
N. N. Burdenko Research Institute of Neurosurgery, Moscow.
Arkh Patol. 1998 Jul-Aug;60(4):8-14.
Tumor-associated proteins are studied immunohistochemically in 86 medulloblastomas (MB). Three main variants of their coexpression (70% of all cases studied) are distinguished. The 1st variant (24 cases): expression of Rb and nm23 proteins and the lack of tenascin expression. The 2nd variant (25 cases): tenascin expression and lack of Rb and nm23 expression. The 3rd variant (12 cases): the expression of tenascin, Rb, p53 and/or bc12. Tenascin-positive MB much more frequently expressed oncoproteins p53, bc12, c-erb B-2 and p30/32, and had higher indices of "growth fraction". Tenascin immunoreactivity and that of other oncoproteins prevailed in MB with desmoplasia and in tumors with immunohistochemical features of neuronal differentiation.
对86例髓母细胞瘤(MB)进行了肿瘤相关蛋白的免疫组织化学研究。区分出了它们共表达的三种主要变体(占所有研究病例的70%)。第一种变体(24例):Rb和nm23蛋白表达,腱生蛋白表达缺失。第二种变体(25例):腱生蛋白表达,Rb和nm23表达缺失。第三种变体(12例):腱生蛋白、Rb、p53和/或bc12的表达。腱生蛋白阳性的MB更频繁地表达癌蛋白p53、bc12、c-erb B-2和p30/32,并且具有更高的“生长分数”指数。腱生蛋白免疫反应性和其他癌蛋白的免疫反应性在具有促结缔组织增生性的MB以及具有神经元分化免疫组织化学特征的肿瘤中占主导。